CAL is one of the few centers in France to offer all the major treatment techniques, including conventional photon therapy, proton therapy, brachytherapy, stereotactic treatments and tomotherapy. The center is recognized worldwide for its expertise and has concluded cooperation agreements with many countries in Europe, Asia and the Middle East, particularly concerning high-energy proton therapy.

CAL's radiation therapy department selected RayStation because it is the only treatment planning system able to handle all treatment delivery systems at the center. The department also appreciated its usability and cutting-edge features to improve patient treatment and efficiency.

The installation will consolidate existing systems at CAL and bring the benefits of advanced RayStation functionality to all radiation therapy treatments. Key features will include unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for IMRT and VMAT optimization and highly accurate dose calculation engines for photon, electron and proton therapy.

RayStation sales have remained strong in France despite the impact of the global pandemic and the order from CAL is one of several major orders from French customers in Q4 2020. In total RaySearch has received orders totaling around 2.7 million EUR in France during the fourth quarter of 2020, excluding support agreements.

Johan Löf, Founder and CEO of RaySearch, says: "Centre Antoine Lacassagne has a worldwide reputation for its treatment quality, research expertise and dedication to use the latest techniques to benefit its patients. We are proud to help CAL achieve its long-term aims, and we are committed to supporting all radiation therapy approaches through a single platform."

About Centre Antoine Lacassagne

Founded in 1961, Center Antoine Lacassagne (CAL) is a world-leading center of excellence for cancer treatment, research and teaching, located in Nice, France. CAL ranks among the top 100 establishments in the world specializing in oncology, and among the top 10 in France. In October 2020, it was recognized by Newsweek in its "World's Best Hospitals in Oncology 2021" ranking. CAL is part of the Unicancer network's federation of Centers for the Fight Against Cancer (CLCC).

About RaySearch

RaySearch is a medical technology company that develops innovative software solutions to improve cancer care. The company markets worldwide its treatment planning system RayStation and next-generation oncology information system RayCare*. Over 2,600 clinics in more than 65 countries use RaySearch software to improve life and outcomes for patients. The company was founded in 2000 and the share has been listed on Nasdaq Stockholm since 2003.

About RayStation

RayStation is a flexible, innovative treatment planning system, chosen by many of the leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for IMRT and VMAT optimization with highly accurate dose engines for photon, electron, proton and carbon ion therapy. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also seamlessly integrates with RayCare, the next-generation oncology information system. By harmonizing the treatment planning, we enable better care for cancer patients worldwide.

* Subject to regulatory clearance in some markets.

More information about RaySearch is available at www.raysearchlabs.com

For further information, please contact:

Johan Löf, Founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00
johan.lof@raysearchlabs.com

Peter Thysell, CFO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)70 661 05 59
peter.thysell@raysearchlabs.com